• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构配体和竞争性配体之间是否存在物理化学差异?

Are there physicochemical differences between allosteric and competitive ligands?

作者信息

Smith Richard D, Lu Jing, Carlson Heather A

机构信息

Department of Medicinal Chemistry, University of Michigan, Ann Arbor, MI, United States of America.

Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States of America.

出版信息

PLoS Comput Biol. 2017 Nov 10;13(11):e1005813. doi: 10.1371/journal.pcbi.1005813. eCollection 2017 Nov.

DOI:10.1371/journal.pcbi.1005813
PMID:29125840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5699844/
Abstract

Previous studies have compared the physicochemical properties of allosteric compounds to non-allosteric compounds. Those studies have found that allosteric compounds tend to be smaller, more rigid, more hydrophobic, and more drug-like than non-allosteric compounds. However, previous studies have not properly corrected for the fact that some protein targets have much more data than other systems. This generates concern regarding the possible skew that can be introduced by the inherent bias in the available data. Hence, this study aims to determine how robust the previous findings are to the addition of newer data. This study utilizes the Allosteric Database (ASD v3.0) and ChEMBL v20 to systematically obtain large datasets of both allosteric and competitive ligands. This dataset contains 70,219 and 9,511 unique ligands for the allosteric and competitive sets, respectively. Physically relevant compound descriptors were computed to examine the differences in their chemical properties. Particular attention was given to removing redundancy in the data and normalizing across ligand diversity and varied protein targets. The resulting distributions only show that allosteric ligands tend to be more aromatic and rigid and do not confirm the increase in hydrophobicity or difference in drug-likeness. These results are robust across different normalization schemes.

摘要

以往的研究比较了变构化合物与非变构化合物的物理化学性质。这些研究发现,与非变构化合物相比,变构化合物往往更小、更刚性、更疏水且更具药物样性质。然而,以往的研究没有恰当地校正某些蛋白质靶点的数据比其他系统多得多这一事实。这引发了对可用数据中固有偏差可能导致的偏差的担忧。因此,本研究旨在确定先前的发现对添加更新数据的稳健程度。本研究利用变构数据库(ASD v3.0)和ChEMBL v20系统地获取变构配体和竞争性配体的大型数据集。该数据集分别包含变构集和竞争集的70219个和9511个独特配体。计算了与物理相关的化合物描述符,以检查它们化学性质的差异。特别注意去除数据中的冗余,并对配体多样性和不同蛋白质靶点进行归一化。所得分布仅表明变构配体往往更具芳香性和刚性,并未证实疏水性增加或药物样性质的差异。这些结果在不同的归一化方案中都是稳健的。

相似文献

1
Are there physicochemical differences between allosteric and competitive ligands?变构配体和竞争性配体之间是否存在物理化学差异?
PLoS Comput Biol. 2017 Nov 10;13(11):e1005813. doi: 10.1371/journal.pcbi.1005813. eCollection 2017 Nov.
2
Chemical, target, and bioactive properties of allosteric modulation.变构调节的化学、靶点及生物活性特性
PLoS Comput Biol. 2014 Apr 3;10(4):e1003559. doi: 10.1371/journal.pcbi.1003559. eCollection 2014 Apr.
3
Moving Beyond Active-Site Detection: MixMD Applied to Allosteric Systems.超越活性位点检测:MixMD应用于变构系统
J Phys Chem B. 2016 Aug 25;120(33):8685-95. doi: 10.1021/acs.jpcb.6b03515. Epub 2016 Jun 17.
4
Exploiting protein flexibility to predict the location of allosteric sites.利用蛋白质的柔性来预测别构位点的位置。
BMC Bioinformatics. 2012 Oct 25;13:273. doi: 10.1186/1471-2105-13-273.
5
Looking for a sequence based allostery definition: a statistical journey at different resolution scales.寻找基于序列的变构定义:不同分辨率尺度下的统计之旅。
J Theor Biol. 2012 Jul 7;304:211-8. doi: 10.1016/j.jtbi.2012.03.005. Epub 2012 Mar 30.
6
Discovery of hidden allosteric sites as novel targets for allosteric drug design.发现隐藏的变构位点作为变构药物设计的新靶点。
Drug Discov Today. 2018 Feb;23(2):359-365. doi: 10.1016/j.drudis.2017.10.001. Epub 2017 Oct 10.
7
Toward understanding the molecular basis for chemical allosteric modulator design.为了理解化学变构调节剂设计的分子基础。
J Mol Graph Model. 2012 Sep;38:324-33. doi: 10.1016/j.jmgm.2012.07.006. Epub 2012 Aug 8.
8
Allosteric site-mediated active site inhibition of PBP2a using Quercetin 3-O-rutinoside and its combination.使用槲皮素 3-O-芸香糖苷及其组合通过变构位点介导对 PBP2a 活性位点的抑制作用
J Biomol Struct Dyn. 2016 Aug;34(8):1778-96. doi: 10.1080/07391102.2015.1092096. Epub 2016 May 4.
9
Connectivity and binding-site recognition: applications relevant to drug design.连接性和结合部位识别:与药物设计相关的应用。
J Comput Chem. 2010 Nov 30;31(15):2677-88. doi: 10.1002/jcc.21561.
10
Allosteric sites can be identified based on the residue-residue interaction energy difference.变构位点可以根据残基间相互作用能的差异来识别。
Proteins. 2015 Aug;83(8):1375-84. doi: 10.1002/prot.24681.

引用本文的文献

1
Allostery Illuminated: Harnessing AI and Machine Learning for Drug Discovery.变构作用揭秘:利用人工智能和机器学习进行药物研发
ACS Med Chem Lett. 2024 Aug 30;15(9):1449-1455. doi: 10.1021/acsmedchemlett.4c00260. eCollection 2024 Sep 12.
2
G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery.G 蛋白偶联受体(GPCRs):结构、机制和药物发现方面的进展。
Signal Transduct Target Ther. 2024 Apr 10;9(1):88. doi: 10.1038/s41392-024-01803-6.
3
An Exploration of the Inhibitory Mechanism of Rationally Screened Benzofuran-1,3,4-Oxadiazoles and-1,2,4-Triazoles as Inhibitors of NS5B RdRp Hepatitis C Virus through Pharmacoinformatic Approaches.

本文引用的文献

1
ChemTreeMap: an interactive map of biochemical similarity in molecular datasets.化学树状图:分子数据集中生化相似性的交互式地图。
Bioinformatics. 2016 Dec 1;32(23):3584-3592. doi: 10.1093/bioinformatics/btw523. Epub 2016 Aug 11.
2
Alloscore: a method for predicting allosteric ligand-protein interactions.Alloscore:一种预测别构配体-蛋白相互作用的方法。
Bioinformatics. 2016 May 15;32(10):1574-6. doi: 10.1093/bioinformatics/btw036. Epub 2016 Jan 22.
3
Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators.
通过药物信息学方法探索合理筛选的苯并呋喃-1,3,4-恶二唑和-1,2,4-三唑作为丙型肝炎病毒NS5B RdRp抑制剂的抑制机制。
Biomedicines. 2023 Nov 17;11(11):3085. doi: 10.3390/biomedicines11113085.
4
Machine learning and protein allostery.机器学习与蛋白质变构。
Trends Biochem Sci. 2023 Apr;48(4):375-390. doi: 10.1016/j.tibs.2022.12.001. Epub 2022 Dec 21.
5
Specifics of Metabolite-Protein Interactions and Their Computational Analysis and Prediction.代谢物-蛋白质相互作用及其计算分析与预测的特点。
Methods Mol Biol. 2023;2554:179-197. doi: 10.1007/978-1-0716-2624-5_12.
6
An Evolutionary Conservation and Druggability Analysis of Enzymes Belonging to the Bacterial Shikimate Pathway.细菌莽草酸途径中酶的进化保守性与成药性分析
Antibiotics (Basel). 2022 May 17;11(5):675. doi: 10.3390/antibiotics11050675.
7
and Inhibition of MATE1 by Tyrosine Kinase Inhibitors.以及酪氨酸激酶抑制剂对多药及毒素外排蛋白1(MATE1)的抑制作用。
Pharmaceutics. 2021 Nov 25;13(12):2004. doi: 10.3390/pharmaceutics13122004.
8
Probe Confined Dynamic Mapping for G Protein-Coupled Receptor Allosteric Site Prediction.用于G蛋白偶联受体变构位点预测的探针受限动态映射
ACS Cent Sci. 2021 Nov 24;7(11):1847-1862. doi: 10.1021/acscentsci.1c00802. Epub 2021 Sep 28.
9
Analysis of the uncharted, druglike property space by self-organizing maps.自组织映射分析未知的、类似药物的物质空间。
Mol Divers. 2022 Oct;26(5):2427-2441. doi: 10.1007/s11030-021-10343-y. Epub 2021 Oct 28.
10
Annotation of Allosteric Compounds to Enhance Bioactivity Modeling for Class A GPCRs.别构化合物的注释以增强 A 类 GPCR 生物活性建模。
J Chem Inf Model. 2020 Oct 26;60(10):4664-4672. doi: 10.1021/acs.jcim.0c00695. Epub 2020 Oct 5.
酰基二氢吡唑并[1,5-a]嘧啶酮作为代谢型谷氨酸受体5的正变构调节剂。
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5115-20. doi: 10.1016/j.bmcl.2015.10.009. Epub 2015 Oct 9.
4
Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092.用变构AKT抑制剂ARQ 092靶向AKT1-E17K和PI3K/AKT信号通路。
PLoS One. 2015 Oct 15;10(10):e0140479. doi: 10.1371/journal.pone.0140479. eCollection 2015.
5
Insights into the allosteric regulation of Syk association with receptor ITAM, a multi-state equilibrium.对Syk与受体免疫受体酪氨酸活化基序(ITAM)结合的变构调节的见解:一种多状态平衡
Phys Chem Chem Phys. 2016 Feb 17;18(8):5807-18. doi: 10.1039/c5cp05417f.
6
ASD v3.0: unraveling allosteric regulation with structural mechanisms and biological networks.ASD v3.0:通过结构机制和生物网络揭示变构调节
Nucleic Acids Res. 2016 Jan 4;44(D1):D527-35. doi: 10.1093/nar/gkv902. Epub 2015 Sep 13.
7
Allosteric sites can be identified based on the residue-residue interaction energy difference.变构位点可以根据残基间相互作用能的差异来识别。
Proteins. 2015 Aug;83(8):1375-84. doi: 10.1002/prot.24681.
8
Chemical, target, and bioactive properties of allosteric modulation.变构调节的化学、靶点及生物活性特性
PLoS Comput Biol. 2014 Apr 3;10(4):e1003559. doi: 10.1371/journal.pcbi.1003559. eCollection 2014 Apr.
9
ASD v2.0: updated content and novel features focusing on allosteric regulation.ASD v2.0:更新内容和关注变构调节的新功能。
Nucleic Acids Res. 2014 Jan;42(Database issue):D510-6. doi: 10.1093/nar/gkt1247. Epub 2013 Nov 28.
10
The ChEMBL bioactivity database: an update.《ChEMBL 生物活性数据库更新》
Nucleic Acids Res. 2014 Jan;42(Database issue):D1083-90. doi: 10.1093/nar/gkt1031. Epub 2013 Nov 7.